Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Lusure Pharmaceutical (also known as Shandong Lusheng Pharmaceutical) is a China-based pharmaceutical company that serves as a core manufacturing and R&D hub for the Hainan Aohe Pharmaceutical Group. Based in Dezhou, Shandong, the company operates high-standard GMP facilities for the production of active pharmaceutical ingredients (APIs), small-volume injections, and oral solid dosage forms. Its commercial portfolio covers therapeutic areas such as respiratory medicine, antifungal treatments, vitamins, and cardiovascular health, featuring products like Fourvitamine for injection and Polyethylene Glycol Electrolytes Powder. In addition to its proprietary drug line, the company functions as a CDMO, providing chemical synthesis and pilot-scale production services to support the broader pipeline of its parent organization, Dezhou Wutai Pharmaceutical Technology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong Lusheng Pharmaceutical.